• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South Korea Thyroid Test Market

    ID: MRFR/HC/49856-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South Korea Thyroid Test Market Research Report By Type (TSH Tests, T4 Tests, T3 Tests, Other) and By End User (Hospital, Diagnostic Laboratories, Research Laboratories and Institutes) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South Korea Thyroid Test Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    South Korea Thyroid Test Market Summary

    The South Korea Thyroid Test market is projected to experience substantial growth from 2024 to 2035.

    Key Market Trends & Highlights

    South Korea Thyroid Test Key Trends and Highlights

    • The market valuation is expected to increase from 44.2 USD Million in 2024 to 104.2 USD Million by 2035.
    • The compound annual growth rate (CAGR) for the market is estimated at 8.1 percent from 2025 to 2035.
    • The growth trajectory indicates a strong demand for thyroid testing services in South Korea over the next decade.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of thyroid disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 44.2 (USD Million)
    2035 Market Size 104.2 (USD Million)
    CAGR (2025-2035) 8.1%

    Major Players

    Daewoong Pharmaceutical, Seegene, Thermo Fisher Scientific, PerkinElmer, Becton Dickinson, Abbott Laboratories, BioRad Laboratories, Agilent Technologies, MediWise, Siemens Healthineers, Roche Diagnostics, Beckman Coulter, Fujifilm, Ortho Clinical Diagnostics, Genexine

    South Korea Thyroid Test Market Trends

    The South Korea Thyroid Test Market is experiencing notable trends driven by increasing awareness about thyroid health among the population. This awareness has been significantly enhanced by educational campaigns led by health organizations, aiming to address the rising incidence of thyroid disorders. As more individuals recognize the importance of early diagnosis, there is a growing demand for thyroid testing services. 

    This shift is often fueled by the aging population in South Korea, as older individuals are more susceptible to thyroid-related conditions. In addition, the digital transformation in healthcare is providing new opportunities for thyroid tests through telemedicine services and home testing kits, allowing patients greater access and convenience.

    In addition, the development of more precise and rapid diagnostic tools, as well as advancements in testing technology, are expected to improve patient care and testing efficiency. This trend is particularly important in a country such as South Korea, where there is a growing emphasis on personalised healthcare solutions and precision medicine. There is a potential for increased partnerships and collaborations between healthcare providers and technology firms to expand the reach and efficacy of thyroid testing in terms of market opportunities. 

    These opportunities are also bolstered by the government's dedication to enhancing healthcare access and quality through a variety of initiatives. Furthermore, there is a trend towards preventive healthcare, which implies that a greater number of individuals may elect to undergo routine thyroid screenings as part of their routine health examinations. In general, these trends are indicative of the changing landscape of the South Korean Thyroid Test Market, which is fostering development and meeting the healthcare requirements of the populace.

      

    Market Segment Insights

    South Korea Thyroid Test Market Segment Insights

    South Korea Thyroid Test Market Segment Insights

    Thyroid Test Market Type Insights

    Thyroid Test Market Type Insights

    The South Korea Thyroid Test Market, segmented by Type, showcases a diverse landscape with several key testing modalities such as TSH Tests, T4 Tests, T3 Tests, and Others. The TSH test is particularly noteworthy as it plays a critical role in diagnosing thyroid dysfunction, making it a frequent choice among healthcare providers due to its reliability. 

    This type of testing not only facilitates early diagnosis but also aids in monitoring treatment efficacy for patients diagnosed with conditions like hypothyroidism and hyperthyroidism. In South Korea, where thyroid problems are increasingly prevalent, the T4 test is vital as it measures thyroxine levels, offering deeper insights about thyroid hormone production.

    The importance of the T4 test is underscored by the government's focus on improving healthcare and enhancing public awareness of thyroid diseases, driving higher testing frequency and demand. Furthermore, T3 Tests provide essential data on triiodothyronine hormone levels, which are crucial for understanding metabolism and energy levels among patients. 

    This test, although less commonly performed than TSH and T4 tests, serves an important diagnostic function, particularly in complex cases where additional hormonal balance assessments are needed.The "Other" category includes various ancillary tests that further assist healthcare providers in painting a comprehensive picture of a patient's thyroid health, thus catering to specialized cases and supporting personalized treatment approaches. 

    Given the rising awareness and medical advancement within the South Korean healthcare sector, coupled with government initiatives focused on chronic disease management, the overall growth prospects remain robust. With a growing aging population who are increasingly susceptible to hormonal imbalances, the South Korea Thyroid Test Market is expected to see continued advancements in testing technologies and methodologies.

    Each segment, while having its unique significance, collectively reflects a comprehensive ecosystem that caters to the evolving needs of the healthcare landscape. This broad segmentation not only enhances diagnosis accuracy but also enables tailored treatment plans, improving patient outcomes significantly in South Korea.

    Thyroid Test Market End User Insights

    Thyroid Test Market End User Insights

    The South Korea Thyroid Test Market is primarily driven by the diverse requirements of its End User segment, including Hospitals, Diagnostic Laboratories, and Research Laboratories and Institutes. Hospitals play a crucial role, providing comprehensive healthcare services, diagnostics, and treatment, making them fundamental in early thyroid disease detection and management. Diagnostic Laboratories are vital as they process a large volume of thyroid testing samples, thus driving efficiency and accuracy in diagnosis, which is essential for effective treatment planning.

    Research Laboratories and Institutes contribute significantly to the South Korea Thyroid Test Market by focusing on R&D activities that pave the way for enhanced diagnostic techniques, innovative testing methods, and improved understanding of thyroid disorders. 

    Furthermore, the growing prevalence of thyroid-related conditions in South Korea creates a substantial demand across these End User categories, leading to advancements in testing technologies and diagnostic capabilities. Overall, the segmentation highlights the importance of collaboration among these entities to enhance patient outcomes and encourage further developments in the thyroid testing landscape.

    Get more detailed insights about South Korea Thyroid Test Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    The South Korea Thyroid Test Market is characterized by a competitive landscape reflecting both rapid technological advancements and increasing healthcare demands. The growing prevalence of thyroid disorders, driven by factors such as lifestyle changes and rising awareness among the population, has intensified the focus of various stakeholders in this sector. In addition to conventional laboratory testing, the market has seen advancements in point-of-care testing and molecular diagnostics, which are gaining traction due to their convenience and fast results. 

    The competitive dynamics involve a mix of established firms and emerging players vying to capture market share by innovating and expanding their product offerings. Regulatory frameworks also play a critical role in shaping market strategies, influencing everything from testing methodologies to product approvals.Daewoong Pharmaceutical has established a prominent presence in the South Korea Thyroid Test Market. The company boasts a portfolio of advanced diagnostic products that cater specifically to thyroid health. Its strengths in this market stem from its significant investments in research and development, positioning it as a key player capable of bringing innovative products to market. 

    The company is also recognized for its strong local partnerships and distribution channels, which enable efficient access to healthcare providers and patients alike. Daewoong Pharmaceutical's strategic approach to maintaining high standards in quality control and customer support has solidified its reputation within the South Korean healthcare landscape, thereby fostering loyalty among healthcare professionals.Seegene has made notable strides in the South Korea Thyroid Test Market, distinguished by its cutting-edge molecular diagnostics capabilities. Known for its unique diagnostic solutions that effectively detect multiple target genes simultaneously, Seegene has positioned itself as a leader in the market for efficient and reliable testing. 

    Key products from Seegene include multiplex real-time PCR kits tailored for thyroid function assessments, which are particularly advantageous for healthcare facilities requiring rapid turnaround times. The company continually invests in technological advancements and research, showcasing a strong commitment to innovation. Seegene has actively pursued mergers and acquisitions to enhance its product range and expand its market presence, thereby strengthening its competitive edge in South Korea. Through its focus on high-quality diagnostics and customer-centric solutions, Seegene has positioned itself as a formidable competitor in the SAouth Korea Thyroid Test Market.

    Key Companies in the South Korea Thyroid Test Market market include

    Industry Developments

    In recent months, the South Korea Thyroid Test Market has seen significant developments, particularly with rising demand for advanced diagnostic solutions. In September 2023, Daewoong Pharmaceutical announced a partnership with Thermo Fisher Scientific to enhance their diagnostic capabilities, focusing on thyroid tests. Furthermore, Seegene has expanded its product portfolio by introducing high-throughput molecular tests tailored for thyroid disorders, marking a pivotal shift in diagnostic precision. 

    The market valuation for companies such as Abbott Laboratories and Roche Diagnostics has surged, influenced by an increase in health awareness and regular screening initiatives by the South Korean government, aimed at early detection of thyroid diseases. In terms of mergers, in June 2023, Becton Dickinson completed its acquisition of a local diagnostics firm to strengthen its foothold in the market. Other companies like BioRad Laboratories and Agilent Technologies continue to innovate, driving growth in point-of-care testing solutions.

    The last few years have been significant for the thyroid test market in South Korea, with aggressive Research and Development efforts from major players, fostering a competitive environment and ensuring a robust pipeline of diagnostic tools and technologies.

    Market Segmentation

    Thyroid Test Market Type Outlook

    • Hospital
    • Diagnostic Laboratories
    • Research Laboratories and Institutes

    Thyroid Test Market End User Outlook

    • Hospital
    • Diagnostic Laboratories
    • Research Laboratories and Institutes

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 41.86(USD Million)
    MARKET SIZE 2024 44.25(USD Million)
    MARKET SIZE 2035 104.25(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.102% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Daewoong Pharmaceutical, Seegene, Thermo Fisher Scientific, PerkinElmer, Becton Dickinson, Abbott Laboratories, BioRad Laboratories, Agilent Technologies, MediWise, Siemens Healthineers, Roche Diagnostics, Beckman Coulter, Fujifilm, Ortho Clinical Diagnostics, Genexine
    SEGMENTS COVERED Type, End User
    KEY MARKET OPPORTUNITIES Rising incidence of thyroid disorders, Increased awareness and screening initiatives, Growth in diagnostic laboratories, Technological advancements in testing, Expanding aging population healthcare needs
    KEY MARKET DYNAMICS increasing prevalence of thyroid disorders, growing awareness and screenings, advancements in diagnostic technologies, rise in healthcare expenditure, supportive government initiatives
    COUNTRIES COVERED South Korea

    FAQs

    What is the projected market size of the South Korea Thyroid Test Market in 2024?

    The South Korea Thyroid Test Market is expected to be valued at 44.25 million USD in 2024.

    What is the expected market size of the South Korea Thyroid Test Market by 2035?

    By 2035, the market is projected to reach 104.25 million USD.

    What is the compound annual growth rate (CAGR) of the South Korea Thyroid Test Market from 2025 to 2035?

    The expected CAGR for the South Korea Thyroid Test Market is 8.102 percent from 2025 to 2035.

    Which type of thyroid test dominated the market share in 2024?

    In 2024, TSH Tests are valued at 20.0 million USD, making it the dominant type in the market.

    What is the projected value of T4 Tests in the South Korea Thyroid Test Market by 2035?

    The projected value for T4 Tests in 2035 is 25.0 million USD.

    Who are the major players in the South Korea Thyroid Test Market?

    Key players include Daewoong Pharmaceutical, Seegene, and Thermo Fisher Scientific among others.

    What challenges does the South Korea Thyroid Test Market face?

    The market faces challenges such as competition among leading players and evolving healthcare regulations.

    What growth opportunities exist in the South Korea Thyroid Test Market?

    Emerging trends in telemedicine and advanced testing technologies present significant growth opportunities.

    How is the T3 Tests segment expected to perform by 2035?

    The T3 Tests segment is expected to grow to a value of 18.0 million USD by 2035.

    What impact do current global conditions have on the South Korea Thyroid Test Market?

    Current global conditions influence market dynamics, driving innovation and changing consumer preferences.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials